Wilson DW et al. |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23318799
|
Smith WL and Edlind TD |
Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384361
|
Dow GS et al. |
Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18644969
|
Arany I et al. |
Epigenetic modifiers exert renal toxicity through induction of p66shc. |
2011 |
Anticancer Res. |
pmid:21965735
|
Shu ST et al. |
Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. |
2010 |
Anticancer Res. |
pmid:20651337
|
Höring E et al. |
The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells. |
2013 |
Anticancer Res. |
pmid:23564772
|
Dressel U et al. |
Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. |
2000 Mar-Apr |
Anticancer Res. |
pmid:10810390
|
Kawano T et al. |
Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. |
2004 Sep-Oct |
Anticancer Res. |
pmid:15517875
|
Noss KR et al. |
Methylation state of the prostate specific membrane antigen (PSMA) CpG island in prostate cancer cell lines. |
2002 May-Jun |
Anticancer Res. |
pmid:12168830
|
Yasuda K et al. |
ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225573
|
Kuwajima A et al. |
The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225587
|
Jasek E et al. |
Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. |
2012 |
Anticancer Res. |
pmid:22753739
|
Nadasi E et al. |
Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells. |
2009 |
Anticancer Res. |
pmid:19528494
|
Jung AR et al. |
Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment. |
2013 |
Anticancer Res. |
pmid:23482750
|
Yap OW et al. |
Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. |
2009 |
Anticancer Res. |
pmid:19331143
|
Emionite L et al. |
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736447
|
Rahim R and Strobl JS |
Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. |
2009 |
Anticancer Drugs |
pmid:19584707
|
Hong S et al. |
Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A. |
2007 |
Anticancer Drugs |
pmid:17704650
|
Monks A et al. |
Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts. |
2009 |
Anticancer Drugs |
pmid:19606018
|
Wittich S et al. |
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. |
2005 |
Anticancer Drugs |
pmid:15930892
|